PREVANTICS SWAB (chlorhexidine gluconate and isopropyl alcohol) by Becton Dickinson. Approved for bacteria. First approved in 2005.
Drug data last refreshed 7h ago · AI intelligence enriched 1mo ago
PREVANTICS SWAB is a topical antiseptic combination of chlorhexidine gluconate and isopropyl alcohol delivered as a single-use swab. It is indicated for skin antisepsis to reduce bacterial colonization prior to invasive procedures. The product works through the combined antimicrobial action of chlorhexidine (broad-spectrum bacterial inhibition) and isopropyl alcohol (rapid antimicrobial activity).
Product is approaching loss of exclusivity with no available spending data; team focus likely shifting toward cost management and market defense rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Working on PREVANTICS SWAB offers experience in mature healthcare product management within a highly commoditized category where differentiation, pricing strategy, and hospital relationship management are critical. This role is ideal for professionals seeking to master cost-driven commercial strategy and institutional selling in anticipation of a competitive LOE transition.
Worked on PREVANTICS SWAB at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.